Bal Pharma (BOM:524824) Property, Plant and Equipment: ₹842 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524824 Bal Pharma Ltd BOM:524824
65 GF Score
Price ₹86.55
GF Value ₹97.41
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Bal Pharma Property, Plant and Equipment?

Bal Pharma BOM:524824 -1.22% 65 Property, Plant and Equipment is ₹842 Mil as of Mar. 2026. GuruFocus rates BOM:524824 with a GF Score™ of 65/100 and a GF Value™ of ₹97.41 (Modestly Undervalued). The stock has 10 warning signs investors should review.

Bal Pharma's quarterly net PPE declined from Sep. 2025 (₹792 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹842 Mil).

Bal Pharma's annual net PPE increased from Mar. 2024 (₹670 Mil) to Mar. 2025 (₹754 Mil) and increased from Mar. 2025 (₹754 Mil) to Mar. 2026 (₹842 Mil).


Bal Pharma  (BOM:524824) Property, Plant and Equipment Explanation

A company with durable competitive advantage doesn't need to constantly upgrade its equipment to stay competitive. The company replaces when it wears out. On the other hand, a company without any advantages must replace to keep pace.

Difference between a company with a moat and one without is that the company with the competitive advantage finances new equipment through internal cash flows, whereas the no advantage company requires debt to finance.

Producing a consistent product that doesn't change equates to consistent profits. There is no need to upgrade plants which frees up cash for other ventures. Think Coca Cola, Johnson & Johnson etc.


Bal Pharma Property, Plant and Equipment Related Terms


Bal Pharma Property, Plant and Equipment Historical Data

* Premium members only.

The historical data trend for Bal Pharma's Property, Plant and Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bal Pharma Property, Plant and Equipment Chart

Bal Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Property, Plant and Equipment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 611.18 641.99 669.60 753.67 841.76

Bal Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Property, Plant and Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 753.67 0.00 792.06 0.00 841.76
BOM:524824
65GF Score
Bal Pharma Ltd BOM:524824
Property, Plant and Equipment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bal Pharma Property, Plant and Equipment Calculation

Property, Plant and Equipment (PPE) are the fixed assets of the companyFixed assets are also known as non-current assets.

Property, plant, and equipment includes assets that will - in the normal course of business - neither be used up in the next year nor will become a part of any product sold to customers.

Some of the most common parts of property, plant, and equipment are:


Land
Buildings (and leasehold improvements)
Transportation equipment
Manufacturing equipment
Office equipment
Office furniture

Companies with lots of property, plant, and equipment often have special categories. For example, railroad property includes:


Track
Ties
Ballast
Bridges
Tunnels
Signals
Locomotives
Freight Cars

There is often a note in the financial statements - found in a company's 10-K - that will explain the different categories of property a company owns.

The market value of property, plant, and equipment can differ tremendously from the book value of property, plant, and equipment.

For example, when Berkshire Hathaway liquidated its textile mills, it had to pay the buyers of the company's manufacturing equipment to haul the equipment away. That property, plant, and equipment was literally worth less than zero. On the other hand, some companies own thousands of acres of land.

All property, plant, and equipment other than land is depreciated. Land is never depreciated. However, land is not marked up to market value either. Under Generally Accepted Accounting Principles (GAAP), land is shown on the balance sheet at cost.

The property, plant, and equipment line shown on the balance sheet is usually net property, plant, and equipment. This means it is the cost of the property, plant, and equipment less accumulated depreciation.

What does a Property, Plant and Equipment of ₹842 Mil mean?
Bal Pharma (BOM:524824) has a Property, Plant and Equipment of ₹842 Mil as of Mar. 2026. The total property, plant and equipment recorded on a company's balance sheet less accumulated depreciation. View historical data on Bal Pharma and its competitors.
Is Bal Pharma's Property, Plant and Equipment too high?
Bal Pharma's current Property, Plant and Equipment is ₹842 Mil. Overall, Bal Pharma has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bal Pharma's Property, Plant and Equipment compare to ZTS?
Bal Pharma's Property, Plant and Equipment of ₹842 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Property, Plant and Equipment for a Drug Manufacturers company?
A good Property, Plant and Equipment depends on the Drug Manufacturers industry context. However, Property, Plant and Equipment should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Property, Plant and Equipment mean?
A high Property, Plant and Equipment can signal that a stock is expensive relative to its fundamentals. The total property, plant and equipment recorded on a company's balance sheet less accumulated depreciation. View historical data on Bal Pharma and its competitors. Bal Pharma's current Property, Plant and Equipment is ₹842 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bal Pharma stock overvalued right now?
Based on GuruFocus' analysis, Bal Pharma (BOM:524824) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹97.41, compared to a current price of ₹86.55 — trading 11.1% below its estimated fair value. The current Property, Plant and Equipment is ₹842 Mil. Bal Pharma's overall GF Score™ is 65/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Property, Plant and Equipment calculated?
Property, Plant and Equipment is calculated from a company's financial statements. For Bal Pharma (BOM:524824), the current Property, Plant and Equipment is ₹842 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bal Pharma (BOM:524824) Overvalued in 2026?

Based on GuruFocus' analysis, Bal Pharma stock appears to be undervalued. The current stock price of ₹86.55 is trading 11.1% below its estimated GF Value™ of ₹97.41. GuruFocus considers Bal Pharma to be Modestly Undervalued.

Key valuation signals for BOM:524824:

  • Property, Plant and Equipment: ₹842 Mil
  • GF Value™: ₹97.41 vs. price of ₹86.55 (11.1% below fair value)
  • GF Score™: 65/100 with 10 warning signs

No single metric tells the full story. See the BOM:524824 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bal Pharma Business Description

Other Exchanges BALPHARMA:India
Address 10/1, Palace Road, 5th Floor, Lakshmi Narayan Complex, Bengaluru, KA, IND, 560052
Bal Pharma Ltd is a pharmaceutical company. It is principally engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients. The company specializes in prescription drugs, generic and over-the-counter products, intravenous infusion, and bulk actives.
65GF Score

Get the complete analysis for BOM:524824

Property, Plant and Equipment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹86.55
Price
₹97.41
GF Value